Found: 25
Select item for more details and to access through your institution.
Mutation‐enhanced international prognostic systems for essential thrombocythaemia and polycythaemia vera.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 2, p. 291, doi. 10.1111/bjh.16380
- By:
- Publication type:
- Article
Ruxolitinib is an effective treatment for CALR-positive patients with myelofibrosis.
- Published in:
- British Journal of Haematology, 2016, v. 173, n. 6, p. 938, doi. 10.1111/bjh.13644
- By:
- Publication type:
- Article
The prognostic contribution of CBL, NRAS, KRAS, RUNX1, and TP53 mutations to mutation‐enhanced international prognostic score systems (MIPSS70/plus/plus v2.0) for primary myelofibrosis.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 1, p. 68, doi. 10.1002/ajh.27136
- By:
- Publication type:
- Article
Concomitant myeloproliferative neoplasm with eosinophilia, B and T cell lymphoblastic lymphoma/leukemia and mast cell proliferation driven by ZMYM2::FGFR1 rearrangement.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 12, p. 1959, doi. 10.1002/ajh.27026
- By:
- Publication type:
- Article
Clonal dynamics and copy number variants by single‐cell analysis in leukemic evolution of myeloproliferative neoplasms.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. 1520, doi. 10.1002/ajh.27013
- By:
- Publication type:
- Article
SF3B1 mutations in primary and secondary myelofibrosis: Clinical, molecular and prognostic correlates.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 9, p. E347, doi. 10.1002/ajh.26648
- By:
- Publication type:
- Article
Integration of multiparameter flow cytometry score improves prognostic stratification provided by standard models in primary myelofibrosis.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 7, p. 846, doi. 10.1002/ajh.26548
- By:
- Publication type:
- Article
Lenalidomide: A double‐edged sword for concomitant multiple myeloma and post‐essential thrombocythemia myelofibrosis.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 6, p. 749, doi. 10.1002/ajh.26153
- By:
- Publication type:
- Article
Mutational analysis of BCORL1 in the leukemic transformation of chronic myeloproliferative neoplasms.
- Published in:
- 2014
- By:
- Publication type:
- Letter
A systematic analysis of bone marrow cells by flow cytometry defines a specific phenotypic profile beyond GPI deficiency in paroxysmal nocturnal hemoglobinuria.
- Published in:
- Cytometry. Part B, 2013, v. 84B, n. 2, p. 71, doi. 10.1002/cyto.b.21064
- By:
- Publication type:
- Article
Co-targeting the PI3K/ mTOR and JAK2 signalling pathways produces synergistic activity against myeloproliferative neoplasms.
- Published in:
- Journal of Cellular & Molecular Medicine, 2013, v. 17, n. 11, p. 1385, doi. 10.1111/jcmm.12162
- By:
- Publication type:
- Article
Evidence for reduced angiogenesis in bone marrow in SSc: immunohistochemistry and multiparametric computerized imaging analysis.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Evidence for reduced angiogenesis in bone marrow in SSc: immunohistochemistry and multiparametric computerized imaging analysis.
- Published in:
- Rheumatology, 2012, v. 51, n. 6, p. 1042, doi. 10.1093/rheumatology/ker447
- By:
- Publication type:
- Article
Phenotypic correlations of CALR mutation variant allele frequency in patients with myelofibrosis.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00786-x
- By:
- Publication type:
- Article
Differential prognostic impact of cytopenic phenotype in prefibrotic vs overt primary myelofibrosis.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 8, p. 1, doi. 10.1038/s41408-022-00713-6
- By:
- Publication type:
- Article
Validation of the IPSET score for thrombosis in patients with prefibrotic myelofibrosis.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 2, p. 1, doi. 10.1038/s41408-020-0289-2
- By:
- Publication type:
- Article
Integrative analysis of copy number and gene expression data suggests novel pathogenetic mechanisms in primary myelofibrosis.
- Published in:
- International Journal of Cancer, 2016, v. 138, n. 7, p. 1657, doi. 10.1002/ijc.29920
- By:
- Publication type:
- Article
Clonal architecture of JAK2V617F mutated cells during treatment with ruxolitinib.
- Published in:
- 2018
- By:
- Publication type:
- Letter
A case of aleukemic mast cell leukemia with an underlying myeloproliferative neoplasm: Morphological and molecular characteristics of a highly aggressive disease.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 12, p. 1622, doi. 10.1002/ajh.25806
- By:
- Publication type:
- Article
Characteristics and clinical correlates of NFE2 mutations in chronic Myeloproliferative neoplasms.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 1, p. E23, doi. 10.1002/ajh.25668
- By:
- Publication type:
- Article
Myelodysplasia as assessed by multiparameter flow cytometry refines prognostic stratification provided by genotypic risk in systemic mastocytosis.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 8, p. 845, doi. 10.1002/ajh.25506
- By:
- Publication type:
- Article
Germline transmission of LNKE208Q variant in a family with myeloproliferative neoplasms.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 9, p. E356, doi. 10.1002/ajh.24437
- By:
- Publication type:
- Article
Prognostic impact of bone marrow fibrosis in primary myelofibrosis. A study of the AGIMM group on 490 patients.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 9, p. 918, doi. 10.1002/ajh.24442
- By:
- Publication type:
- Article
Epidemiology and clinical relevance of mutations in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 359 patients of the AGIMM group.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 7, p. 681, doi. 10.1002/ajh.24377
- By:
- Publication type:
- Article
What Do Molecular Tests Add to Prognostic Stratification in MF: Is It Time to Add These to Our Clinical Practice?
- Published in:
- Current Hematologic Malignancy Reports, 2015, v. 10, n. 4, p. 380, doi. 10.1007/s11899-015-0285-y
- By:
- Publication type:
- Article